Send us Feedback

Stryker (SYK)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

SYK » Topics » SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS

This excerpt taken from the SYK 8-K filed Oct 30, 2009.

SECTION 9   FINANCIAL STATEMENTS AND EXHIBITS

 

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS.

 

(c)   

Exhibits

The following exhibits are included with this Report:

99.1

Press release announcing retirement of John W. Brown, as Chairman of the Board

of Directors of Stryker Corporation

99.2

Press release announcing modification of the Company's dividend policy and

declaration of cash transition dividend

 

This excerpt taken from the SYK 8-K filed Nov 23, 2005.

SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01  Financial Statements and Exhibits.

(c)        Exhibits

            Exhibit 10.1                  Credit Agreement, dated as of November 18, 2005, among Stryker Corporation and certain subsidiaries, as designated borrowers, and Howmedica International S. de R.L., as the term loan borrower, Bank of America, N.A., as administrative agent, swing line lender, offshore currency funding fronting lender and issuer of letters of credit, JPMorgan Chase Bank, N.A., as syndication agent, The Bank Of Tokyo-Mitsubishi, Ltd., Chicago Branch, Barclays Bank Plc and PNP Paribas, as co-documentation agents, Wells Fargo Bank, N.A., Scotiabanc Inc., Mizuho Corporate Bank (USA), Société Générale and Wachovia Bank, N.A., as co-managing agents, and the other lenders party thereto, and Banc of America Securities LLC and J.P. Morgan Securities Inc. as joint lead arrangers and joint book managers. 

 

 

EXCERPTS ON THIS PAGE:

8-K
Oct 30, 2009
8-K
Nov 23, 2005

RELATED TOPICS for SYK:

"SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS" elsewhere:

Boston Scientific (BSX)
JOHNSON & JOHNSON (JNJ)
ABIOMED (ABMD)
AMERIGROUP (AGP)
AngioDynamics (ANGO)
ArthroCare (ARTC)
Alphatec Holdings (ATEC)
AtriCure (ATRC)
BARD C R INC (BCR)
BECTON DICKINSON & CO (BDX)
BioLase Technology (BLTI)
Cantel Medical (CMN)
Centene (CNC)
CONMED (CNMD)
Cooper Companies (COO)
Conceptus (CPTS)
DaVita (DVA)
Haemonetics (HAE)
Home Diagnostics (HDIX)
Integra LifeSciences Holdings (IART)
ICU Medical (ICUI)
Kensey Nash (KNSY)
LeMaitre Vascular (LMAT)
Merit Medical Systems (MMSI)
Memry (MRY)
NuVasive (NUVA)
Owens & Minor (OMI)
Osteotech (OSTE)
OraSure Technologies (OSUR)
Rochester Medical (ROCM)
SenoRx (SENO)
SonoSite (SONO)
STERIS (STE)
Teleflex (TFX)
Vascular Solutions (VASC)
Orthovita (VITA)
WELLCARE HEALTH PLANS, INC. (WCG)
West Pharmaceutical Services (WST)
Young Innovations (YDNT)
Medtronic (MDT)
Baxter International (BAX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki